How does lenalidomide target the chronic lymphocytic leukemia microenvironment?

Kater, AP, Tonino, SH, Egle, A, Ramsay, AG, Blood. 2014 Oct 2,124(14):2184-9. doi: 10.1182/blood-2014-05-578286. Epub 2014 Aug 26.

Old and new news in CLL: „It“s the pathway, stupid!“.

Egle, A, Blood. 2014 Aug 14,124(7):989-90. doi: 10.1182/blood-2014-05-574145.

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.

Jaeger, U, Trneny, M, Melzer, H, Praxmarer, M, Nawarawong, W, Ben Yehuda, D, Goldstein, D, Mihaljevic, B, Ilhan, O, Ballova, V, Hedenus, M, Hsiao, LT, Au, WY, Burgstaller, S, Weidinger, G, Keil, F, Dittrich, C, Skrabs, C, Klingler, A, Chott, A, Fridrik, MA, Greil, R. Haematologica. 2015, 100(7): 955-963.

AID/APOBEC deaminases and cancer.

Rebhandl, S, Huemer, M, Greil, R, Geisberger, R. Oncoscience. 2015, 2(4): 320-333.

The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.

Troppan, KT, Melchardt, T, Deutsch, A, Schlick, K, Stojakovic, T, Bullock, MD, Reitz, D, Beham-Schmid, C, Weiss, L, Neureiter, D, Wenzl, K, Greil, R, Neumeister, P, Egle, A, Pichler, M. Eur J Haematol. 2015, 95(6): 538-544.

Treatment of Patients With Myelodysplastic Syndrome With Lenalidomide in Clinical Routine in Austria.

Aschauer, G, Greil, R, Linkesch, W, Nösslinger, T, Stauder, R, Burgstaller, S, Fiegl, M, Fridrik, M, Girschikofsky, M, Keil, F, Petzer, A. Clin Lymphoma Myeloma Leuk. 2015, 15(11): e143-e149.

Lenalidomide and dexamethasone for acute light chain-induced renal failure: a phase II study.

Ludwig, H, Rauch, E, Kuehr, T, Adam, Z, Weissmann, A, Kasparu, H, Autzinger, EM, Heintel, D, Greil, R, Poenisch, W, MГјldГјr, E, Zojer, N. Haematologica. 2015, 100(3):385-391.

Prognostic factors for remission of and survival in acquired hemophilia A (AHA): results from the GTH-AH 01/2010 study.

Tiede, A, Klamroth, R, Scharf, RE, Trappe, RU, Holstein, K, Huth-Kühne, A, Gottstein, S, Geisen, U, Schenk, J, Scholz, U, Schilling, K, Neumeister, P, Miesbach, W, Manner, D, Greil, R, von Auer, C, Krause, M, Leimkühler, K, Kalus, U, Blumtritt, J, Werwitzke, S, Budde, E, Koch, A, Knöbl, P. Blood. 2015, 125(7): 1091-1097.

Longitudinal analysis of 2293 NSCLC patients: a comprehensive study from the TYROL registry.

Kocher, F, Hilbe, W, Seeber, A, Pircher, A, Schmid, T, Greil, R, Auberger, J, Nevinny-Stickel, M, Sterlacci, W, Tzankov, A, Jamnig, H, Kohler, K, Zabernigg, A, Frotscher, J, Oberaigner, W, Fiegl, M. LUNG CANCER. 2015, 87(2): 193-200.

Primary antifungal prophylaxis with micafungin in patients with haematological malignancies: real-life data from a retrospective single-centre observational study.

Nachbaur, D, Angelova, O, Orth-Holler, D, Ditlbacher, A, Lackner, M, Auberger, J, Lass-Florl, C. EUR J HAEMATOL. 2015, 94(3): 258-264.